Advertisement
For older adults with knee osteoarthritis

Spironolactone No Benefit for Knee OA in Older Adults

0
No improvements seen in symptoms, physical function, or health-related quality of life
A significant number of patients continue to take prescription opioids many months after joint replacement surgery

Many Still on Opioids Six Months After Total Joint Arthroplasty

0
Study findings highlight growing epidemic
Reducing the dietary glycemic index is associated with a reduction in uric acid levels among overweight and obese adults

Low Glycemic Index Diet Linked to Drop in Uric Acid Levels

0
Reducing glycemic index lowers uric acid levels, regardless of percentage of carbohydrates in diet
Most patients prefer that physicians wear white coats

Patients Like to See Physicians Wearing White Coats

0
Patients prefer doctors who wear 'professional' attire, survey finds
A new training module can improve training for medical assistants

AMA Module Promotes Training of Medical Assistants

0
Module contributed by medical group in New Jersey includes interactive learning, eliminates testing

May 2016 Briefing – Rheumatology

0
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for May 2016. This roundup includes the latest...
A new communication toolkit created by the Agency for Healthcare Research and Quality can help health care organizations and providers communicate with patients and families when harm occurs to patients.

AHRQ Communication Toolkit Can Help After Patient Harm Occurs

0
Toolkit helps patients, families, clinicians, and administrators discuss what happened
For patients with rheumatoid arthritis

Glucocorticoid Use Ups Diabetes Risk in Rheumatoid Arthritis

0
Risk influenced by dosage and duration of treatment for glucocorticoid use in past six months
Uninsurance rates have decreased since the introduction of the Affordable Care Act

Remaining Uninsured May Be Difficult to Reach Via ACA

0
Reaching the remaining uninsured may be difficult due to lack of Medicaid expansion on the state level
The U.S. Food and Drug Administration has approved the first-ever buprenorphine implant to treat opioid dependence

FDA Approves Probuphine Implant for Opioid Dependence

0
New form of treatment designed to last six months